{"indexed": {"date-parts": [[2023, 2, 21]], "date-time": "2023-02-21T05:58:03Z", "timestamp": 1676959083884}, "reference-count": 71, "publisher": "MDPI AG", "issue": "4", "license": [{"start": {"date-parts": [[2023, 2, 20]], "date-time": "2023-02-20T00:00:00Z", "timestamp": 1676851200000}, "content-version": "vor", "delay-in-days": 0, "URL": "https://creativecommons.org/licenses/by/4.0/"}], "funder": [{"name": "German Research Foundation", "award": ["398410809", "233886668", "431549029\u2014A01", "269018619"]}, {"name": "European Union\u2019s Horizon 2020 Marie Sk\u0142odowska-Curie", "award": ["956185"]}, {"name": "Center for Molecular Medicine Cologne", "award": ["C18"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["IJMS"], "abstract": "<jats:p>For SMA patients with only two SMN2 copies, available therapies might be insufficient to counteract lifelong motor neuron (MN) dysfunction. Therefore, additional SMN-independent compounds, supporting SMN-dependent therapies, might be beneficial. Neurocalcin delta (NCALD) reduction, an SMA protective genetic modifier, ameliorates SMA across species. In a low-dose SMN-ASO-treated severe SMA mouse model, presymptomatic intracerebroventricular (i.c.v.) injection of Ncald-ASO at postnatal day 2 (PND2) significantly ameliorates histological and electrophysiological SMA hallmarks at PND21. However, contrary to SMN-ASOs, Ncald-ASOs show a shorter duration of action limiting a long-term benefit. Here, we investigated the longer-term effect of Ncald-ASOs by additional i.c.v. bolus injection at PND28. Two weeks after injection of 500 \u00b5g Ncald-ASO in wild-type mice, NCALD was significantly reduced in the brain and spinal cord and well tolerated. Next, we performed a double-blinded preclinical study combining low-dose SMN-ASO (PND1) with 2\u00d7 i.c.v. Ncald-ASO or CTRL-ASO (100 \u00b5g at PND2, 500 \u00b5g at PND28). Ncald-ASO re-injection significantly ameliorated electrophysiological defects and NMJ denervation at 2 months. Moreover, we developed and identified a non-toxic and highly efficient human NCALD-ASO that significantly reduced NCALD in hiPSC-derived MNs. This improved both neuronal activity and growth cone maturation of SMA MNs, emphasizing the additional protective effect of NCALD-ASO treatment.</jats:p>", "DOI": "10.3390/ijms24044198", "type": "journal-article", "created": {"date-parts": [[2023, 2, 20]], "date-time": "2023-02-20T10:27:01Z", "timestamp": 1676888821000}, "page": "4198", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Long-Term SMN- and Ncald-ASO Combinatorial Therapy in SMA Mice and NCALD-ASO Treatment in hiPSC-Derived Motor Neurons Show Protective Effects"], "prefix": "10.3390", "volume": "24", "author": [{"ORCID": "http://orcid.org/0000-0002-8334-6802", "authenticated-orcid": false, "given": "Anixa", "family": "Mui\u00f1os-B\u00fchl", "sequence": "first", "affiliation": [{"name": "Institute of Human Genetics, University of Cologne, 50931 Cologne, Germany"}, {"name": "Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne, Germany"}]}, {"given": "Roman", "family": "Rombo", "sequence": "additional", "affiliation": [{"name": "Institute of Human Genetics, University of Cologne, 50931 Cologne, Germany"}, {"name": "Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne, Germany"}]}, {"given": "Karen K.", "family": "Ling", "sequence": "additional", "affiliation": [{"name": "IONIS Pharmaceuticals, Carlsbad, CA 92010, USA"}]}, {"ORCID": "http://orcid.org/0000-0003-4356-7675", "authenticated-orcid": false, "given": "Eleonora", "family": "Zilio", "sequence": "additional", "affiliation": [{"name": "Institute of Human Genetics, University of Cologne, 50931 Cologne, Germany"}, {"name": "Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne, Germany"}]}, {"given": "Frank", "family": "Rigo", "sequence": "additional", "affiliation": [{"name": "IONIS Pharmaceuticals, Carlsbad, CA 92010, USA"}]}, {"given": "C. Frank", "family": "Bennett", "sequence": "additional", "affiliation": [{"name": "IONIS Pharmaceuticals, Carlsbad, CA 92010, USA"}]}, {"ORCID": "http://orcid.org/0000-0003-4051-5191", "authenticated-orcid": false, "given": "Brunhilde", "family": "Wirth", "sequence": "additional", "affiliation": [{"name": "Institute of Human Genetics, University of Cologne, 50931 Cologne, Germany"}, {"name": "Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne, Germany"}, {"name": "Center for Rare Diseases Cologne, University Hospital of Cologne, 50931 Cologne, Germany"}]}], "member": "1968", "published-online": {"date-parts": [[2023, 2, 20]]}, "reference": [{"key": "ref_1", "doi-asserted-by": "crossref", "first-page": "1723", "DOI": "10.1056/NEJMoa1702752", "article-title": "Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy", "volume": "377", "author": "Finkel", "year": "2017", "journal-title": "N. Engl. J. Med."}, {"key": "ref_2", "doi-asserted-by": "crossref", "first-page": "915", "DOI": "10.1056/NEJMoa2009965", "article-title": "Risdiplam in Type 1 Spinal Muscular Atrophy", "volume": "384", "author": "Baranello", "year": "2021", "journal-title": "N. Engl. J. Med."}, {"key": "ref_3", "doi-asserted-by": "crossref", "first-page": "427", "DOI": "10.1056/NEJMoa2102047", "article-title": "Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls", "volume": "385", "author": "Darras", "year": "2021", "journal-title": "N. Engl. J. Med."}, {"key": "ref_4", "doi-asserted-by": "crossref", "first-page": "1713", "DOI": "10.1056/NEJMoa1706198", "article-title": "Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy", "volume": "377", "author": "Mendell", "year": "2017", "journal-title": "N. Engl. J. Med."}, {"key": "ref_5", "doi-asserted-by": "crossref", "first-page": "625", "DOI": "10.1056/NEJMoa1710504", "article-title": "Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy", "volume": "378", "author": "Mercuri", "year": "2018", "journal-title": "N. Engl. J. Med."}, {"key": "ref_6", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1016/0092-8674(95)90460-3", "article-title": "Identification and characterization of a spinal muscular atrophy-determining gene", "volume": "80", "author": "Lefebvre", "year": "1995", "journal-title": "Cell"}, {"key": "ref_7", "doi-asserted-by": "crossref", "first-page": "306", "DOI": "10.1016/j.tins.2020.11.009", "article-title": "Spinal Muscular Atrophy: In the Challenge Lies a Solution", "volume": "44", "author": "Wirth", "year": "2021", "journal-title": "Trends Neurosci."}, {"key": "ref_8", "doi-asserted-by": "crossref", "first-page": "231", "DOI": "10.1146/annurev-genom-102319-103602", "article-title": "Twenty-Five Years of Spinal Muscular Atrophy Research: From Phenotype to Genotype to Therapy, and What Comes Next", "volume": "21", "author": "Wirth", "year": "2020", "journal-title": "Annu. Rev. Genom. Hum. Genet."}, {"key": "ref_9", "doi-asserted-by": "crossref", "first-page": "6307", "DOI": "10.1073/pnas.96.11.6307", "article-title": "A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy", "volume": "96", "author": "Lorson", "year": "1999", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "ref_10", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1038/ng0797-265", "article-title": "Correlation between severity and SMN protein level in spinal muscular atrophy", "volume": "16", "author": "Lefebvre", "year": "1997", "journal-title": "Nat. Genet."}, {"key": "ref_11", "doi-asserted-by": "crossref", "first-page": "197", "DOI": "10.1016/j.nmd.2017.11.004", "article-title": "Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics", "volume": "28", "author": "Finkel", "year": "2018", "journal-title": "Neuromuscul. Disord."}, {"key": "ref_12", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1016/j.nmd.2017.11.005", "article-title": "Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care", "volume": "28", "author": "Mercuri", "year": "2018", "journal-title": "Neuromuscul. Disord."}, {"key": "ref_13", "doi-asserted-by": "crossref", "first-page": "1961", "DOI": "10.1093/hmg/6.11.1961", "article-title": "Expression of the SMN gene, the spinal muscular atrophy determining gene, in the mammalian central nervous system", "volume": "6", "author": "Battaglia", "year": "1997", "journal-title": "Hum. Mol. Genet."}, {"key": "ref_14", "doi-asserted-by": "crossref", "first-page": "1205", "DOI": "10.1093/hmg/6.8.1205", "article-title": "The survival motor neuron protein in spinal muscular atrophy", "volume": "6", "author": "Coovert", "year": "1997", "journal-title": "Hum. Mol. Genet."}, {"key": "ref_15", "doi-asserted-by": "crossref", "first-page": "299", "DOI": "10.1016/j.bbagrm.2016.12.008", "article-title": "Diverse role of survival motor neuron protein", "volume": "1860", "author": "Singh", "year": "2017", "journal-title": "Biochim. Biophys. Acta Gene Regul. Mech."}, {"key": "ref_16", "doi-asserted-by": "crossref", "unstructured": "Zilio, E., Piano, V., and Wirth, B. (2022). Mitochondrial Dysfunction in Spinal Muscular Atrophy. Int. J. Mol. Sci., 23.", "DOI": "10.3390/ijms231810878"}, {"key": "ref_17", "doi-asserted-by": "crossref", "first-page": "826608", "DOI": "10.3389/fncel.2022.826608", "article-title": "R-loop Mediated DNA Damage and Impaired DNA Repair in Spinal Muscular Atrophy", "volume": "16", "author": "Cuartas", "year": "2022", "journal-title": "Front. Cell Neurosci."}, {"key": "ref_18", "doi-asserted-by": "crossref", "first-page": "40", "DOI": "10.1016/j.molmed.2012.11.002", "article-title": "Spinal muscular atrophy: Going beyond the motor neuron", "volume": "19", "author": "Hamilton", "year": "2013", "journal-title": "Trends Mol. Med."}, {"key": "ref_19", "doi-asserted-by": "crossref", "first-page": "2851", "DOI": "10.1093/hmg/ddy195", "article-title": "Temporal and tissue-specific variability of SMN protein levels in mouse models of spinal muscular atrophy", "volume": "27", "author": "Groen", "year": "2018", "journal-title": "Hum. Mol. Genet."}, {"key": "ref_20", "doi-asserted-by": "crossref", "first-page": "785", "DOI": "10.1172/JCI72017", "article-title": "Requirement of enhanced Survival Motoneuron protein imposed during neuromuscular junction maturation", "volume": "124", "author": "Kariya", "year": "2014", "journal-title": "J. Clin. Investig."}, {"key": "ref_21", "doi-asserted-by": "crossref", "first-page": "1239", "DOI": "10.1038/s41556-020-00577-7", "article-title": "SMN-primed ribosomes modulate the translation of transcripts related to spinal muscular atrophy", "volume": "22", "author": "Lauria", "year": "2020", "journal-title": "Nat. Cell Biol."}, {"key": "ref_22", "doi-asserted-by": "crossref", "first-page": "585", "DOI": "10.1016/j.cell.2008.03.031", "article-title": "SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing", "volume": "133", "author": "Zhang", "year": "2008", "journal-title": "Cell"}, {"key": "ref_23", "doi-asserted-by": "crossref", "first-page": "842", "DOI": "10.1016/j.nmd.2019.09.007", "article-title": "Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study", "volume": "29", "author": "Bertini", "year": "2019", "journal-title": "Neuromuscul. Disord."}, {"key": "ref_24", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.1186/s13023-021-01783-8", "article-title": "Newborn screening for spinal muscular atrophy in Germany: Clinical results after 2 years", "volume": "16", "author": "Vill", "year": "2021", "journal-title": "Orphanet. J. Rare Dis."}, {"key": "ref_25", "doi-asserted-by": "crossref", "first-page": "1381", "DOI": "10.1038/s41591-022-01866-4", "article-title": "Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: The Phase III SPR1NT trial", "volume": "28", "author": "Strauss", "year": "2022", "journal-title": "Nat. Med."}, {"key": "ref_26", "doi-asserted-by": "crossref", "first-page": "1390", "DOI": "10.1038/s41591-022-01867-3", "article-title": "Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: The Phase III SPR1NT trial", "volume": "28", "author": "Strauss", "year": "2022", "journal-title": "Nat. Med."}, {"key": "ref_27", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1111/dmcn.15286", "article-title": "Financial cost and quality of life of patients with spinal muscular atrophy identified by symptoms or newborn screening", "volume": "65", "author": "Dangouloff", "year": "2023", "journal-title": "Dev. Med. Child. Neurol."}, {"key": "ref_28", "doi-asserted-by": "crossref", "first-page": "524", "DOI": "10.1126/science.1155085", "article-title": "Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy", "volume": "320", "author": "Oprea", "year": "2008", "journal-title": "Science"}, {"key": "ref_29", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.1016/j.ajhg.2017.01.005", "article-title": "Neurocalcin Delta Suppression Protects against Spinal Muscular Atrophy in Humans and across Species by Restoring Impaired Endocytosis", "volume": "100", "author": "Riessland", "year": "2017", "journal-title": "Am. J. Hum. Genet."}, {"key": "ref_30", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1016/j.ajhg.2019.05.008", "article-title": "NCALD Antisense Oligonucleotide Therapy in Addition to Nusinersen further Ameliorates Spinal Muscular Atrophy in Mice", "volume": "105", "author": "Schneider", "year": "2019", "journal-title": "Am. J. Hum. Genet."}, {"key": "ref_31", "doi-asserted-by": "crossref", "first-page": "647", "DOI": "10.1016/j.ajhg.2016.07.014", "article-title": "The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype", "volume": "99", "author": "Hosseinibarkooie", "year": "2016", "journal-title": "Am. J. Hum. Genet."}, {"key": "ref_32", "doi-asserted-by": "crossref", "first-page": "5275", "DOI": "10.1007/s00018-021-03843-5", "article-title": "Plastin 3 in health and disease: A matter of balance", "volume": "78", "author": "Wolff", "year": "2021", "journal-title": "Cell Mol. Life Sci."}, {"key": "ref_33", "doi-asserted-by": "crossref", "first-page": "E4377", "DOI": "10.1073/pnas.1600015113", "article-title": "Decreased function of survival motor neuron protein impairs endocytic pathways", "volume": "113", "author": "Dimitriadi", "year": "2016", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "ref_34", "doi-asserted-by": "crossref", "first-page": "e89970", "DOI": "10.1172/jci.insight.89970", "article-title": "Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy", "volume": "2", "author": "Kaifer", "year": "2017", "journal-title": "JCI Insight"}, {"key": "ref_35", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1016/j.omtm.2018.01.007", "article-title": "Plastin 3 Promotes Motor Neuron Axonal Growth and Extends Survival in a Mouse Model of Spinal Muscular Atrophy", "volume": "9", "author": "Alrafiah", "year": "2018", "journal-title": "Mol. Ther. Methods Clin. Dev."}, {"key": "ref_36", "doi-asserted-by": "crossref", "unstructured": "Walsh, M.B., Janzen, E., Wingrove, E., Hosseinibarkooie, S., Muela, N.R., Davidow, L., Dimitriadi, M., Norabuena, E.M., Rubin, L.L., and Wirth, B. (2020). Genetic modifiers ameliorate endocytic and neuromuscular defects in a model of spinal muscular atrophy. BMC Biol., 18.", "DOI": "10.1186/s12915-020-00845-w"}, {"key": "ref_37", "doi-asserted-by": "crossref", "first-page": "105795", "DOI": "10.1016/j.nbd.2022.105795", "article-title": "Combinatorial ASO-mediated therapy with low dose SMN and the protective modifier Chp1 is not sufficient to ameliorate SMA pathology hallmarks", "volume": "171", "author": "Rombo", "year": "2022", "journal-title": "Neurobiol. Dis."}, {"key": "ref_38", "doi-asserted-by": "crossref", "first-page": "2343", "DOI": "10.1093/brain/awy167", "article-title": "CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis", "volume": "141", "author": "Janzen", "year": "2018", "journal-title": "Brain"}, {"key": "ref_39", "doi-asserted-by": "crossref", "first-page": "703", "DOI": "10.1002/mus.21838", "article-title": "Compound muscle action potential and motor function in children with spinal muscular atrophy", "volume": "42", "author": "Lewelt", "year": "2010", "journal-title": "Muscle Nerve"}, {"key": "ref_40", "doi-asserted-by": "crossref", "first-page": "34", "DOI": "10.1002/acn3.23", "article-title": "Electrophysiological Biomarkers in Spinal Muscular Atrophy: Preclinical Proof of Concept", "volume": "1", "author": "Arnold", "year": "2014", "journal-title": "Ann. Clin. Transl. Neurol."}, {"key": "ref_41", "doi-asserted-by": "crossref", "unstructured": "Panopoulos, A.D., Ruiz, S., Yi, F., Herrerias, A., Batchelder, E.M., and Izpisua Belmonte, J.C. (2011). Rapid and highly efficient generation of induced pluripotent stem cells from human umbilical vein endothelial cells. PLoS ONE, 6.", "DOI": "10.1371/journal.pone.0019743"}, {"key": "ref_42", "doi-asserted-by": "crossref", "first-page": "398", "DOI": "10.1093/hmg/dds437", "article-title": "VPA response in SMA is suppressed by the fatty acid translocase CD36", "volume": "22", "author": "Garbes", "year": "2013", "journal-title": "Hum. Mol. Genet."}, {"key": "ref_43", "doi-asserted-by": "crossref", "first-page": "801", "DOI": "10.1083/jcb.200304128", "article-title": "Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons", "volume": "163", "author": "Rossoll", "year": "2003", "journal-title": "J. Cell Biol."}, {"key": "ref_44", "doi-asserted-by": "crossref", "first-page": "793", "DOI": "10.1083/jcb.201604117", "article-title": "Differential roles of alpha-, beta-, and gamma-actin in axon growth and collateral branch formation in motoneurons", "volume": "216", "author": "Moradi", "year": "2017", "journal-title": "J. Cell Biol."}, {"key": "ref_45", "doi-asserted-by": "crossref", "first-page": "294", "DOI": "10.1016/S0006-8993(98)00750-1", "article-title": "Neurocalcin-immunopositive nerve terminals in the muscle spindle, Golgi tendon organ and motor endplate", "volume": "808", "author": "Iino", "year": "1998", "journal-title": "Brain Res."}, {"key": "ref_46", "doi-asserted-by": "crossref", "first-page": "599", "DOI": "10.1042/bj3630599", "article-title": "Identification of Ca2+-dependent binding partners for the neuronal calcium sensor protein neurocalcin delta: Interaction with actin, clathrin and tubulin", "volume": "363", "author": "Ivings", "year": "2002", "journal-title": "Biochem. J."}, {"key": "ref_47", "doi-asserted-by": "crossref", "first-page": "30133", "DOI": "10.1074/jbc.M114.570440", "article-title": "Collapsin response mediator protein 4 regulates growth cone dynamics through the actin and microtubule cytoskeleton", "volume": "289", "author": "Khazaei", "year": "2014", "journal-title": "J. Biol. Chem."}, {"key": "ref_48", "doi-asserted-by": "crossref", "first-page": "1212", "DOI": "10.1126/science.1137406", "article-title": "Hardwiring the brain: Endocannabinoids shape neuronal connectivity", "volume": "316", "author": "Berghuis", "year": "2007", "journal-title": "Science"}, {"key": "ref_49", "doi-asserted-by": "crossref", "first-page": "3017", "DOI": "10.1016/S0140-6736(16)31408-8", "article-title": "Treatment of infantile-onset spinal muscular atrophy with nusinersen: A phase 2, open-label, dose-escalation study", "volume": "388", "author": "Finkel", "year": "2016", "journal-title": "Lancet"}, {"key": "ref_50", "doi-asserted-by": "crossref", "first-page": "930", "DOI": "10.1038/s41593-021-00827-3", "article-title": "Gain of toxic function by long-term AAV9-mediated SMN overexpression in the sensorimotor circuit", "volume": "24", "author": "Tattoli", "year": "2021", "journal-title": "Nat. Neurosci."}, {"key": "ref_51", "first-page": "e52899", "article-title": "Electrophysiological Motor Unit Number Estimation (MUNE) Measuring Compound Muscle Action Potential (CMAP) in Mouse Hindlimb Muscles", "volume": "103", "author": "Arnold", "year": "2015", "journal-title": "J. Vis. Exp."}, {"key": "ref_52", "unstructured": "Sumner, C.J., Paushkin, S., and Ko, C.P. (2017). Spinal Musculat Atrophy: Disease Mechanisms and Therapy, Academic Press."}, {"key": "ref_53", "doi-asserted-by": "crossref", "first-page": "22", "DOI": "10.1186/s13395-022-00305-9", "article-title": "Mouse models of SMA show divergent patterns of neuronal vulnerability and resilience", "volume": "12", "author": "Woschitz", "year": "2022", "journal-title": "Skelet. Muscle"}, {"key": "ref_54", "doi-asserted-by": "crossref", "first-page": "709", "DOI": "10.1016/j.tins.2020.07.002", "article-title": "Harmony Lost: Cell-Cell Communication at the Neuromuscular Junction in Motor Neuron Disease", "volume": "43", "author": "Gromova", "year": "2020", "journal-title": "Trends Neurosci."}, {"key": "ref_55", "doi-asserted-by": "crossref", "first-page": "30", "DOI": "10.1038/s41572-019-0079-y", "article-title": "Myasthenia gravis", "volume": "5", "author": "Gilhus", "year": "2019", "journal-title": "Nat. Rev. Dis. Primers"}, {"key": "ref_56", "doi-asserted-by": "crossref", "first-page": "834", "DOI": "10.1016/j.ajhg.2008.01.014", "article-title": "Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice", "volume": "82", "author": "Hua", "year": "2008", "journal-title": "Am. J. Hum. Genet."}, {"key": "ref_57", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.1038/nature10485", "article-title": "Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model", "volume": "478", "author": "Hua", "year": "2011", "journal-title": "Nature"}, {"key": "ref_58", "doi-asserted-by": "crossref", "first-page": "1605", "DOI": "10.1093/hmg/11.14.1605", "article-title": "Survival motor neuron (SMN) protein: Role in neurite outgrowth and neuromuscular maturation during neuronal differentiation and development", "volume": "11", "author": "Fan", "year": "2002", "journal-title": "Hum. Mol. Genet."}, {"key": "ref_59", "doi-asserted-by": "crossref", "first-page": "4865", "DOI": "10.1093/hmg/ddr425", "article-title": "The spinal muscular atrophy disease protein SMN is linked to the Rho-kinase pathway via profilin", "volume": "20", "author": "Nolle", "year": "2011", "journal-title": "Hum. Mol. Genet."}, {"key": "ref_60", "doi-asserted-by": "crossref", "first-page": "54", "DOI": "10.1177/1073858417705059", "article-title": "The Actin Cytoskeleton in SMA and ALS: How Does It Contribute to Motoneuron Degeneration?", "volume": "24", "author": "Hensel", "year": "2018", "journal-title": "Neuroscientist"}, {"key": "ref_61", "doi-asserted-by": "crossref", "first-page": "2451", "DOI": "10.1093/hmg/9.16.2451", "article-title": "Animal models of spinal muscular atrophy", "volume": "9", "author": "Monani", "year": "2000", "journal-title": "Hum. Mol. Genet."}, {"key": "ref_62", "doi-asserted-by": "crossref", "first-page": "905", "DOI": "10.1038/nn.4561", "article-title": "Reduced sensory synaptic excitation impairs motor neuron function via Kv2.1 in spinal muscular atrophy", "volume": "20", "author": "Fletcher", "year": "2017", "journal-title": "Nat. Neurosci."}, {"key": "ref_63", "doi-asserted-by": "crossref", "first-page": "78", "DOI": "10.1016/j.neuroscience.2020.10.038", "article-title": "Functional Abnormalities of Cerebellum and Motor Cortex in Spinal Muscular Atrophy Mice", "volume": "452", "author": "Tharaneetharan", "year": "2021", "journal-title": "Neuroscience"}, {"key": "ref_64", "doi-asserted-by": "crossref", "first-page": "376", "DOI": "10.1523/JNEUROSCI.2142-20.2020", "article-title": "Chronic Pharmacological Increase of Neuronal Activity Improves Sensory-Motor Dysfunction in Spinal Muscular Atrophy Mice", "volume": "41", "author": "Simon", "year": "2021", "journal-title": "J. Neurosci."}, {"key": "ref_65", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1083/jcb.200703187", "article-title": "Defective Ca2+ channel clustering in axon terminals disturbs excitability in motoneurons in spinal muscular atrophy", "volume": "179", "author": "Jablonka", "year": "2007", "journal-title": "J. Cell Biol."}, {"key": "ref_66", "doi-asserted-by": "crossref", "first-page": "66", "DOI": "10.1038/71709", "article-title": "A mouse model for spinal muscular atrophy", "volume": "24", "author": "Chang", "year": "2000", "journal-title": "Nat. Genet."}, {"key": "ref_67", "doi-asserted-by": "crossref", "first-page": "1328", "DOI": "10.1093/hmg/dds540", "article-title": "Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality", "volume": "22", "author": "Ackermann", "year": "2013", "journal-title": "Hum. Mol. Genet."}, {"key": "ref_68", "first-page": "e2968", "article-title": "Delivery of therapeutic agents through intracerebroventricular (ICV) and intravenous (IV) injection in mice", "volume": "56", "author": "Glascock", "year": "2011", "journal-title": "J. Vis. Exp."}, {"key": "ref_69", "first-page": "e50326", "article-title": "Direct intraventricular delivery of drugs to the rodent central nervous system", "volume": "75", "author": "DeVos", "year": "2013", "journal-title": "J. Vis. Exp."}, {"key": "ref_70", "doi-asserted-by": "crossref", "first-page": "861", "DOI": "10.1038/s41467-017-00911-y", "article-title": "HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients", "volume": "8", "author": "Guo", "year": "2017", "journal-title": "Nat. Commun."}, {"key": "ref_71", "doi-asserted-by": "crossref", "first-page": "526", "DOI": "10.1007/s00018-022-04544-3", "article-title": "CAPRIN1(P512L) causes aberrant protein aggregation and associates with early-onset ataxia", "volume": "79", "author": "Natarajan", "year": "2022", "journal-title": "Cell. Mol. Life Sci."}], "container-title": ["International Journal of Molecular Sciences"], "language": "en", "link": [{"URL": "https://www.mdpi.com/1422-0067/24/4/4198/pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2023, 2, 20]], "date-time": "2023-02-20T10:30:11Z", "timestamp": 1676889011000}, "score": 221.32298, "resource": {"primary": {"URL": "https://www.mdpi.com/1422-0067/24/4/4198"}}, "issued": {"date-parts": [[2023, 2, 20]]}, "references-count": 71, "journal-issue": {"issue": "4", "published-online": {"date-parts": [[2023, 2]]}}, "alternative-id": ["ijms24044198"], "URL": "http://dx.doi.org/10.3390/ijms24044198", "ISSN": ["1422-0067"], "issn-type": [{"value": "1422-0067", "type": "electronic"}], "subject": ["Inorganic Chemistry", "Organic Chemistry", "Physical and Theoretical Chemistry", "Computer Science Applications", "Spectroscopy", "Molecular Biology", "General Medicine", "Catalysis"], "published": {"date-parts": [[2023, 2, 20]]}}